Top

Published in:

01-04-2004 | Original Article

Matrix metalloproteinase-9 is elevated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice

Authors: Stefan Lorenzl, Noel Calingasan, Lichuan Yang, David S. Albers, Shuei Shugama, Jason Gregorio, H. W. Krell, Jason Chirichigno, Tong Joh, M. Flint Beal

Published in: NeuroMolecular Medicine | Issue 2/2004

Title: Matrix metalloproteinase-9 is elevated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice
Authors: Stefan Lorenzl
Noel Calingasan
Lichuan Yang
David S. Albers
Shuei Shugama
Jason Gregorio
H. W. Krell
Jason Chirichigno
Tong Joh
M. Flint Beal
Publication date: 01-04-2004
Publisher: Humana Press
Published in: NeuroMolecular Medicine / Issue 2/2004
Print ISSN: 1535-1084
Electronic ISSN: 1559-1174
DOI: https://doi.org/10.1385/NMM:5:2:119

2024 ASCO Annual Meeting

Springer Medicine

Matrix metalloproteinase-9 is elevated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice

2024 ASCO Annual Meeting

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2/2004

Genetic association analysis of neuronal nitric oxide synthase gene polymorphism with tardive dyskinesia

Differential expression of oxidative phosphorylation genes in patients with Alzheimer’s disease

The S-adenosyl homocysteine hydrolase inhibitor 3-deaza-adenosine prevents oxidative damage and cognitive impairment following folate and vitamin E deprivation in a murine model of age-related, oxidative stress-induced neurodegeneration

α-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer’s disease